Antibody-fluorophore conjugates provide optical contrast to delineate tumor margins and detect metastatic disease during resection.
Passive immunotherapy with isolated anti-tau antibodies reduces tau aggregation without inducing neurofibrillary tangles or axonal damage.
Single-domain antibodies target stable macrophage markers to bypass poor solid tumor penetration and reduce aspecific binding.
RT-PCR isolation of human antibody genes from vaccinated subjects resolves immunogenicity issues while preserving binding reliability.
Segmented agents with enzyme-sensitive linkers reduce systemic toxicities while enabling real-time monitoring.
Antibodies targeting FZD10 deliver cytotoxic effects to synovial sarcoma cells while sparing normal tissue toxicity.
Cell-permeable MRI sensors detect calcium ions via paramagnetic relaxation, enabling deep-tissue imaging beyond optical limits.
Humanized hMP-E-8.3 antibody conjugated to a duocarmycin derivative targets Endosialin-expressing cells.
Zwitterionic metal chelators reduce non-specific interactions to improve signal-to-background ratios in diagnostic imaging.
Cholane-PEG conjugates self-assemble into compact nanocarriers that improve tumor penetration while maintaining high drug loading capacity.
Porous 3D nanostructures embed core nanoparticles to boost payload capacity while preserving circulation time.
Ivabradine lowers heart rate via selective If current inhibition to enhance coronary artery imaging resolution.